CN1745842A - Chinese medicine for treating acute and chronic hepatitis and hepatocirrhosis, its preparation thereof - Google Patents
Chinese medicine for treating acute and chronic hepatitis and hepatocirrhosis, its preparation thereof Download PDFInfo
- Publication number
- CN1745842A CN1745842A CNA200510094248XA CN200510094248A CN1745842A CN 1745842 A CN1745842 A CN 1745842A CN A200510094248X A CNA200510094248X A CN A200510094248XA CN 200510094248 A CN200510094248 A CN 200510094248A CN 1745842 A CN1745842 A CN 1745842A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- hours
- chinese medicine
- radix sophorae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
An orally taken Chinese medicine for treating acute or chronic hepatitis and hepatocirrhosis is prepared from 7 Chinese-medicinal materials including subprostrate sophora root, astragalus root, human placenta, ground bettle, etc.
Description
Technical field
The invention belongs to technical field of Chinese medicines.Particularly a kind of Chinese medicine for the treatment of hepatopathys such as acute hepatitis, chronic hepatitis, liver cirrhosis and preparation method thereof.
Background technology
Chronic hepatitis is a kind of common frequently-occurring disease, wherein the hepatitis virus carrier in state-owned people more than 200,000,000, most of hepatic lesions are chronic progressive external development, its main pathological change is that inflammation and hepatic fibrosis exist simultaneously, and latter's direct result is a liver cirrhosis, even develops into hepatocarcinoma.Domestic at present even external all the shortage, effectively reversed the clinical treatment medicine that hepatic fibrosis becomes.Therefore, the ideal treatment medicine that the research and development anti-hepatic fibrosis becomes is the important topic of current medical research.
Summary of the invention
The objective of the invention is to overcome the shortcoming that prior art exists, a kind of hepatopathy symptom and sign that is used to improve is provided, promote liver function recovery, microcirculation improvement improves body's immunological function, the Chinese medicine of prevention, the development of blocking-up liver fiber.Another object of the present invention provides the preparation method of this medicine.
The objective of the invention is to be achieved through the following technical solutions:
Medicament selection Radix Sophorae Tonkinensis of the present invention, the Radix Astragali, Placenta Hominis, Carapax Trionycis, Eupolyphaga Seu Steleophaga, Radix Curcumae and rhizoma sparganic carry out prescription.These medicines are combined to make the merit of the existing blood circulation promoting and blood stasis dispelling of this Chinese medicine, and the merit of nourishing the blood and yin is arranged again, makes it invigorate blood circulation and just do not hinder.Wherein the monarch drug Radix Sophorae Tonkinensis has antiviral, falls the enzyme function, the Radix Astragali can improve body immunity; Carapax Trionycis, Eupolyphaga Seu Steleophaga, rhizoma sparganic, Radix Curcumae have the merit of stronger blood circulation promoting and blood stasis dispelling, can reduce globulin, rise albumin, and the Placenta Hominis vigorate qi and replenish the blood is mended deficiency of both YIN and YANG, and the function of this reduction of returning is arranged.
The consumption of each crude drug of medicine of the present invention is that the inventor gropes to sum up to draw in a large number, all has curative effect preferably in the scope of following weight parts:
Radix Sophorae Tonkinensis 25-30 part
Radix Astragali 20-25 part
Carapax Trionycis 5-15 part
Eupolyphaga Seu Steleophaga 5-10 part
Placenta Hominis 4-10 part
Radix Curcumae 8-15 part
Rhizoma sparganic 7-12 part.
Be preferably:
27 parts of Radix Sophorae Tonkinensiss
23 parts of the Radixs Astragali
8 parts of Carapax Trionycis
5 parts of Eupolyphaga Seu Steleophagas
4 parts of Placenta Hominiss
8 parts of Radix Curcumaes
7 parts of rhizoma sparganic.
Chinese medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations.For example can be with these crude drug decocting together except that Placenta Hominis, the condensed water decocting liquid is mixed and made into the Placenta Hominis powder more then.But these are not used in restriction protection scope of the present invention.
Preferably, preparation method of the present invention is as follows:
(1) takes by weighing each crude drug, standby in proportion;
(2) with described weight proportion Radix Sophorae Tonkinensis 2/3, the Radix Astragali 5/6 with rhizoma sparganic section after add in the water of 5 times of amounts and soaked about 3 hours;
The medical material that (3) will soak decocted 3 hours; The decocting that medicinal residues is added again 2 times of amounts boiled 2 hours, slagging-off; Merge decocting liquid twice;
(4) medicinal liquid after will merging precipitates about 12 hours, gets its supernatant and gets medicinal liquid;
(5) concentrate: will go up clear liquid medicine and be concentrated into the concentrated solution that relative density is 1.2-1.4;
(6) with described weight proportion Radix Sophorae Tonkinensis 1/3, the Radix Astragali 1/6 and Placenta Hominis, Eupolyphaga Seu Steleophaga, Carapax Trionycis, Radix Curcumae be ground into powder respectively after mix homogeneously get mixed powder;
(7) mixed powder of step (6) is added in step (5) the gained concentrated solution make even soft material, granulate with 22 mesh sieves;
(8) dry, 20 mesh sieve granulate;
(9) incapsulate, get finished medicines.
Medicine of the present invention has the function of blood circulation promoting and blood stasis dispelling, nourishing the blood and yin, and rapid-action, taking convenience, mouthfeel are good.Treatment acute, chronic hepatitis, liver cirrhosis all had better curative effect.
The specific embodiment
Further set forth the present invention and effect with clinical practice by the following examples.
Embodiment 1
Prescription: Radix Sophorae Tonkinensis 270g Radix Astragali 230g Placenta Hominis 40g
Carapax Trionycis 80g Eupolyphaga Seu Steleophaga 50g Radix Curcumae 80g rhizoma sparganic 70g
Method for making:
1, get in proportion Radix Sophorae Tonkinensis, the Radix Astragali, rhizoma sparganic, rinse well, the section; Get the above-mentioned three kinds of medical materials after cleaning, add water 4100g and soaked 3 hours;
2, above-mentioned medical material decocts with water twice, 3 hours for the first time, adds water 1640g for the second time and fries in shallow oil 2 hours; Remove medicinal residues twice medicinal liquid merged, precipitate 12 hours, remove its supernatant liquid filtering, get medicinal liquid; Filtrate concentrates 18 hours, is concentrated into relative density and reaches 1.2-1.4;
3, take by weighing a certain proportion of Placenta Hominis powder, Eupolyph aga sinesis Walker, turmeric powder, turtle ' s carapace powder, Radix Sophorae Tonkinensis powder, astragalus membranaceus powder, mix homogeneously.
4, with concentrated solution mixed material is made soft material, 22 mesh sieves are granulated, 60 ℃ of dryings, and 20 mesh sieve granulate, dry powder mixing incapsulate makes 1000 of capsules (every 0.45g).
Embodiment 2
Prescription: Radix Sophorae Tonkinensis 250g Radix Astragali 240g Placenta Hominis 50g
Carapax Trionycis 70g Eupolyphaga Seu Steleophaga 60g Radix Curcumae 90g rhizoma sparganic 70g
Method for making:
1, get in proportion Radix Sophorae Tonkinensis, the Radix Astragali, rhizoma sparganic, rinse well, the section; Get the above-mentioned three kinds of medical materials after cleaning, soaked 3 hours;
2, above-mentioned medical material decocts with water twice, and 3 hours for the first time, 2 hours for the second time; Remove medicinal residues twice medicinal liquid merged, precipitate 12 hours, remove its supernatant liquid filtering, get medicinal liquid; Filtrate concentrates 18 hours, is concentrated into relative density and reaches 1.2-1.4;
3, take by weighing a certain proportion of Placenta Hominis powder, Eupolyph aga sinesis Walker, turmeric powder, turtle ' s carapace powder, Radix Sophorae Tonkinensis powder, astragalus membranaceus powder, mix homogeneously.
4, with concentrated solution mixed material is made soft material, 22 mesh sieves are granulated, 60 ℃ of dryings, and 20 mesh sieve granulate, dry powder mixing incapsulate makes 1000 of capsules (every 0.45g).
The test example
Below further set forth the beneficial effect of medicine of the present invention by the test example,
1, physical data: clinical hospital: the 97th hospital of Xuzhou City, Jiangsu Province PLA:
Hospitalization 310 examples.
2, diagnostic criteria: press hepatitis diagnostic criteria.
3, criterion of therapeutical effect:
Produce effects: cardinal symptom disappears, liver, the corresponding retraction of splenomegaly, and YB, A, G, ALT recover normal;
Effectively: the cardinal symptom hepatosplenomegaly makes moderate progress, and it is normal that TB, ALT recover, and A raises, and G descends, but does not reach normal;
Invalid: cardinal symptom and hepatosplenomegaly are improved, and A and G do not have improvement, and TB and ALT do not recover normal or raise.
4, instructions of taking: with embodiment 1 medicine, every day 3 times, each 4 (every 0.45 gram).
5, clinical treatment result:
Produce effects: 71 examples are effective: 205 examples are invalid: 34 examples
Total effective rate: 89.03%
Claims (3)
1, a kind of Chinese medicine for the treatment of acute, chronic hepatitis, liver cirrhosis is characterized in that it is made by following bulk drugs:
Radix Sophorae Tonkinensis 25-30 part
Radix Astragali 20-25 part
Carapax Trionycis 5-15 part
Eupolyphaga Seu Steleophaga 5-10 part
Placenta Hominis 4-10 part
Radix Curcumae 8-15 part
Rhizoma sparganic 7-12 part
2, Chinese medicine according to claim 1 is characterized in that the consumption of each crude drug is:
27 parts of Radix Sophorae Tonkinensiss
23 parts of the Radixs Astragali
8 parts of Carapax Trionycis
5 parts of Eupolyphaga Seu Steleophagas
4 parts of Placenta Hominiss
8 parts of Radix Curcumaes
7 parts of rhizoma sparganic.
3, a kind of claim 1 or 2 described preparation method of Chinese medicine is characterized in that comprising the following steps:
(1) takes by weighing each crude drug, standby in proportion;
(2) with described weight proportion Radix Sophorae Tonkinensis 2/3, the Radix Astragali 5/6 with rhizoma sparganic section after add in the water of 5 times of amounts and soaked about 3 hours;
The medical material that (3) will soak decocted 3 hours; The decocting that medicinal residues is added again 2 times of amounts boiled 2 hours, slagging-off; Merge decocting liquid twice;
(4) medicinal liquid after will merging precipitates about 12 hours, gets its supernatant and gets medicinal liquid;
(5) concentrate: will go up clear liquid medicine and be concentrated into the concentrated solution that relative density is 1.2-1.4;
(6) with described weight proportion Radix Sophorae Tonkinensis 1/3, the Radix Astragali 1/6 and Placenta Hominis, Eupolyphaga Seu Steleophaga, Carapax Trionycis, Radix Curcumae be ground into powder respectively after mix homogeneously get mixed powder;
(7) mixed powder of step (6) is added in step (5) the gained concentrated solution make even soft material, granulate with 22 mesh sieves;
(8) dry, 20 mesh sieve granulate;
(9) incapsulate, get finished medicines.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510094248XA CN100396323C (en) | 2005-09-03 | 2005-09-03 | Chinese medicine for treating acute and chronic hepatitis and hepatocirrhosis, its preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510094248XA CN100396323C (en) | 2005-09-03 | 2005-09-03 | Chinese medicine for treating acute and chronic hepatitis and hepatocirrhosis, its preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1745842A true CN1745842A (en) | 2006-03-15 |
CN100396323C CN100396323C (en) | 2008-06-25 |
Family
ID=36165660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200510094248XA Expired - Fee Related CN100396323C (en) | 2005-09-03 | 2005-09-03 | Chinese medicine for treating acute and chronic hepatitis and hepatocirrhosis, its preparation thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100396323C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101112585B (en) * | 2006-07-26 | 2011-10-26 | 毛顺卿 | Fuyijikui Chinese patent drug for treating cirrhosis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1142384A (en) * | 1996-01-15 | 1997-02-12 | 贺力坤 | Preparation of medicine for hepatic diseases |
CN1319587C (en) * | 2003-12-19 | 2007-06-06 | 赵忠勇 | Medicine powder for liver and spleen diseases |
-
2005
- 2005-09-03 CN CNB200510094248XA patent/CN100396323C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101112585B (en) * | 2006-07-26 | 2011-10-26 | 毛顺卿 | Fuyijikui Chinese patent drug for treating cirrhosis |
Also Published As
Publication number | Publication date |
---|---|
CN100396323C (en) | 2008-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1186071C (en) | Medicines composition for treating chronic heart failure and its prepn | |
CN1201776C (en) | Medicines composition for treating diabetes and its prepn | |
CN1476849A (en) | Medicine composition for promoting blood circulation and removing stasis | |
CN1745842A (en) | Chinese medicine for treating acute and chronic hepatitis and hepatocirrhosis, its preparation thereof | |
CN1173718C (en) | Medicine for curing lupus erythematosus etc. immune diseases induced diseases | |
CN1943620A (en) | Chinese medicine composition for treating cardio-cerabral vascular diseases and its preparing method | |
CN1107711A (en) | Hypoglycemic compound capsule | |
CN1319587C (en) | Medicine powder for liver and spleen diseases | |
CN1285367C (en) | Medicinal preparation for treating diabetes and its preparation method | |
CN1051468C (en) | Capsule for curing rheumatism | |
CN1294013A (en) | Medicine for treating prostatic hyperplasia | |
CN1772149A (en) | Chinese medicine composition for treating coronary heart disease and its prepn | |
CN100342879C (en) | Liver fibrosis treating prepn and its process | |
CN1287821C (en) | Combination of medication in use for treating coronary heart disease and preparation method | |
CN1150014C (en) | Lupus erythematosus treating medicine | |
CN101057912A (en) | Medicine for treating hepatitis and cirrhosis ascites and its preparation method | |
CN1879846A (en) | A Chinese medicinal preparation for treating rheumatism, hyperosteogeny and osteoporosis and method for preparing same | |
CN1239179C (en) | Chinese medicine for treating diabetes and preparation method therefor | |
CN1150015C (en) | Medicine for treating leucocytopenia caused by lupus erythematosus | |
CN1235615C (en) | Chinese medicinal preparation for treating coronary heart disease, cerebral thrombus and cerebral infarct | |
CN1323656C (en) | Medicine for treating rheumatic arthritis and preparation technology of its spray agent | |
CN1141183A (en) | Compound Vernonia anthelmintica tablet for treating vitiligo | |
CN1583020A (en) | Chinese medicinal preparation for hepatitis and its preparing method (1) | |
CN1418699A (en) | Naolingsu Kawa masticatory tablet for treating sleepless and preparation method thereof | |
CN101053633A (en) | Medicinal composition for treating rheumatalgia pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080625 Termination date: 20120903 |